JP2001508440A5 - - Google Patents

Download PDF

Info

Publication number
JP2001508440A5
JP2001508440A5 JP1998530897A JP53089798A JP2001508440A5 JP 2001508440 A5 JP2001508440 A5 JP 2001508440A5 JP 1998530897 A JP1998530897 A JP 1998530897A JP 53089798 A JP53089798 A JP 53089798A JP 2001508440 A5 JP2001508440 A5 JP 2001508440A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998530897A
Other languages
English (en)
Japanese (ja)
Other versions
JP5170723B2 (ja
JP2001508440A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/023358 external-priority patent/WO1998030208A1/en
Publication of JP2001508440A publication Critical patent/JP2001508440A/ja
Publication of JP2001508440A5 publication Critical patent/JP2001508440A5/ja
Application granted granted Critical
Publication of JP5170723B2 publication Critical patent/JP5170723B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP53089798A 1997-01-10 1997-12-18 活性薬剤の制御放出用錠剤 Expired - Fee Related JP5170723B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78176197A 1997-01-10 1997-01-10
US08/781,761 1997-01-10
PCT/US1997/023358 WO1998030208A1 (en) 1997-01-10 1997-12-18 Tablet for the controlled release of active agents

Publications (3)

Publication Number Publication Date
JP2001508440A JP2001508440A (ja) 2001-06-26
JP2001508440A5 true JP2001508440A5 (enExample) 2005-06-16
JP5170723B2 JP5170723B2 (ja) 2013-03-27

Family

ID=25123834

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53089798A Expired - Fee Related JP5170723B2 (ja) 1997-01-10 1997-12-18 活性薬剤の制御放出用錠剤

Country Status (8)

Country Link
US (1) US6033685A (enExample)
EP (1) EP0951279A1 (enExample)
JP (1) JP5170723B2 (enExample)
AR (1) AR010875A1 (enExample)
AU (1) AU5609998A (enExample)
CA (1) CA2277220A1 (enExample)
WO (1) WO1998030208A1 (enExample)
ZA (1) ZA9880B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
GB9901688D0 (en) * 1999-01-26 1999-03-17 Unilever Plc Detergent compositions
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6960357B2 (en) * 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
US7052706B2 (en) * 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
US20030152622A1 (en) * 2001-10-25 2003-08-14 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral diuretic
US20030104052A1 (en) * 2001-10-25 2003-06-05 Bret Berner Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
CA2409552A1 (en) * 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
EP1455751A1 (en) * 2001-12-20 2004-09-15 Pharmacia Corporation Zero-order sustained released dosage forms and method of making the same
AU2003225837B2 (en) * 2002-03-15 2008-11-06 Forest Laboratories Holdings Limited NE and 5-HT reuptake inhibitors for treating visceral pain syndromes
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
CA2507042A1 (en) * 2002-12-06 2004-06-24 Ucb Farchim, S.A. Tablet comprising efletirizine and pseudoephedrine
US20040228830A1 (en) * 2003-01-28 2004-11-18 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
EP1599189A4 (en) * 2003-03-04 2009-07-01 Nostrum Pharmaceuticals Inc FORMULATION WITH CONTROLLED RELEASE AND WITH WATER-REPELLENT MATERIAL AS A MEANS FOR DELAYED RELEASE
SI1575565T1 (sl) * 2003-08-08 2010-04-30 Biovail Lab Int Srl Tableta bupropion hidroklorida z modificiranim sproĹˇŽŤanjem
EP1715856B1 (en) * 2003-12-31 2012-07-11 Actavis Group PTC ehf. Atomoxetine formulations
EP1781262A1 (en) * 2004-07-29 2007-05-09 Sanofi-Aventis Pharmaceutical multilayer tablet for controlled_release of active ingredients with highly ph-dependent solubility
US20080248107A1 (en) * 2005-08-24 2008-10-09 Rubicon Research Pvt. Ltd. Controlled Release Formulation
US8691272B2 (en) 2005-12-30 2014-04-08 Intelgenx Corp. Multilayer tablet
JP4953673B2 (ja) * 2006-03-22 2012-06-13 リンテック株式会社 経口投与剤
US20080107725A1 (en) * 2006-10-13 2008-05-08 Albano Antonio A Pharmaceutical Solid Dosage Forms Comprising Amorphous Compounds Micro-Embedded in Ionic Water-Insoluble Polymers
KR100885029B1 (ko) * 2007-02-07 2009-02-23 지엘팜텍 주식회사 경구투여용 서방성 삼중정제
KR20100136967A (ko) * 2008-02-15 2010-12-29 썬 파마 어드밴스트 리서치 컴패니 리미티드 파열 효과가 감소된 방출 제어 경구 정제
US20100260842A1 (en) * 2009-04-06 2010-10-14 Rashmi Nair Pseudoephedrine pharmaceutical formulations
CA2775091A1 (en) * 2009-08-05 2011-02-10 Lupin Limited Controlled release pharmaceutical compositions of milnacipran
US9572909B2 (en) * 2009-09-14 2017-02-21 Virginia Commonwealth University Electrospun nerve guides for nerve regeneration designed to modulate nerve architecture
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
US10485770B2 (en) 2009-12-21 2019-11-26 Aptapharma, Inc. Functionally-coated multilayer tablets
SG174658A1 (en) 2010-04-01 2011-10-28 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
MX394356B (es) 2016-01-20 2025-03-24 Theravida Inc Métodos y composiciones para tratar hiperhidrosis.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE564759A (enExample) * 1955-12-22
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US5114719A (en) * 1987-04-29 1992-05-19 Sabel Bernhard A Extended drug delivery of small, water-soluble molecules
ES2037179T3 (es) * 1987-11-25 1993-06-16 American Cyanamid Company Sistema de liberacion sostenida (controlada) para bloqueadores de canales de calcio de dihidropiridina.
JPH04360826A (ja) * 1991-06-07 1992-12-14 Bayer Yakuhin Kk 放出制御製剤
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
US5593694A (en) * 1991-10-04 1997-01-14 Yoshitomi Pharmaceutical Industries, Ltd. Sustained release tablet
JPH0791500B2 (ja) * 1991-10-25 1995-10-04 太田インキ製造株式会社 印刷インキ組成物
IT1256393B (it) * 1992-11-17 1995-12-04 Inverni Della Beffa Spa Forme matriciali multistrato per il rilascio controllato di principi attivi
IT1265240B1 (it) * 1993-11-30 1996-10-31 Ekita Investments Nv Compressa farmaceutica a rilascio controllato, di forma lenticolare
CA2136810A1 (en) * 1994-06-30 1995-12-31 Franklin M. C. Chen Absorbent structure including an adhesive

Similar Documents

Publication Publication Date Title
JP2000502280A5 (enExample)
JP2000501018A5 (enExample)
JP2000500076A5 (enExample)
JP2001500098A5 (enExample)
JP2000501324A5 (enExample)
JP2000500055A5 (enExample)
JP2000500026A5 (enExample)
JP2000502472A5 (enExample)
JP2000501338A5 (enExample)
JP2000500874A5 (enExample)
JP2000512184A5 (enExample)
JP2000502425A5 (enExample)
JP2000502485A5 (enExample)
JP2000502568A5 (enExample)
JP2000500912A5 (enExample)
JP2000502570A5 (enExample)
JP2001508440A5 (enExample)
JP2000501229A5 (enExample)
JP2000500857A5 (enExample)
JP2000513979A5 (enExample)
JP2000502316A5 (enExample)
JP2000502714A5 (enExample)
JP2001502089A5 (enExample)
JP2000501569A5 (enExample)
JP2000500184A5 (enExample)